Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
Inactive on SAM.gov — responses were due 26 Aug 2026 · Unrestricted (full and open) · Centers for Disease Control and Prevention (CDC), HHS · Atlanta, GA · NAICS 541715 · Solicitation 97469
Following NAICS 541715? Get new solicitations in it by email as they post — no account needed.
A newer version of this notice has been posted. SAM.gov republished solicitation 97469 on 26 August 2026. This page is kept because it is a real record, but the current requirement, dates and attachments are on the latest version. Read the latest version →
What happened next
SAM.gov marked this notice inactive — responses were due 26 August 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology)) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format prescribed in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued. The Centers for Disease Control and Prevention (CDC) is issuing Request for Quotation (RFQ) No. 75D301-26-Q-79208 using the procedures of FAR Part 12, Acquisition of Commercial Products and Commercial Services, in conjunction with FAR Part 13, Simplified Acquisition Procedures, for the acquisition of Market Forecast Analyses for West Nile Virus (WNV) Vaccine and Anti-WNV Monoclonal Antibody for Prophylaxis. The acquisition will result in the award of a Time-and-Materials (T&M) purchase order. Description of Requirement The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), requires contractor support to conduct two comprehensive market forecast analyses: Human West Nile virus (WNV) vaccine Anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis The contractor shall perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications in accordance with the attached Statement of Work (SOW). Product or Service Code: AN11 Health R&D Services, Epidemiology NAICS Code: 541715- Research and Development in the Physical Engineering, and Life Sciences Period of Performance: September 30, 2026 September 29, 2027 (12 months). Delivery Services shall be performed in accordance with the attached Statement of Work. Deliverables shall be submitted in accordance with the deliverable schedule identified in Section 7 of the Statement of Work. Monthly invoicing is required. Submission Requirements Offerors shall submit the following: Completed pricing for all CLINs. A Time-and-Materials quotation for the entire period of performance. Written acknowledgement of the Statement of Work confirming the ability to perform the required services. Active System for Award Management (SAM) registration, including UEI, with no active exclusions. Any required Artificial Intelligence (AI) disclosures and AI Compliance and Risk Management Plan, if applicable.
Version history
SAM.gov has posted 3 notices under solicitation 97469, oldest first.
17 August 2026 — Combined Synopsis/Solicitation (this page)
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
